{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:38:22Z","timestamp":1783478302947,"version":"3.55.0"},"reference-count":30,"publisher":"Bioscientifica","issue":"9","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":162,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Small intestinal neuroendocrine tumors (SI-NETs) represent the most frequent neoplasms of the small intestine, with loss of chromosome 18 as the most common genetic aberration. To date, no highly frequently mutated genes have been identified on chromosome 18 or elsewhere. This study aimed to explore the potential role of methyl-CpG binding domain protein 2 (MBD2), located at 18q21.2, as a tumor suppressor gene in SI-NETs. By immunohistochemistry, we found undetectable or very low levels of MBD2 expression in 64% of the analyzed SI-NETs, and overall, very low levels of mRNA and protein expression were observed. Overexpression of MBD2 in the SI-NET cell line, GOT1, reduced cell growth and induced apoptosis, though cell migration remained unaffected. In addition, MBD2 expression decreased cell proliferation and migration capacity of the neuroendocrine cells NCI-H727 but showed no effect on apoptosis. Furthermore, MBD2 expression in both cell lines was found to upregulate E-cadherin but downregulate the levels of N-cadherin and vimentin in GOT1 and NCI-H72, respectively, as determined by western blot analysis. These results suggest that MBD2 plays a role in inhibiting the epithelial-mesenchymal transition process and may function as a potential tumor suppressor gene in SI-NETs. Future studies to elucidate the underlying mechanisms are warranted.<\/jats:p>","DOI":"10.1530\/ec-25-0169","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T11:19:44Z","timestamp":1757675984000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-10","source":"Crossref","is-referenced-by-count":1,"title":["Loss of MBD2 is associated with tumor growth in small intestinal neuroendocrine tumors"],"prefix":"10.1530","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2943-0613","authenticated-orcid":true,"given":"Elham","family":"Barazeghi","sequence":"first","affiliation":[{"name":"Department of Surgical Sciences, Uppsala University, Uppsala University Hospital, Rudbeck Laboratory , ,","place":["Uppsala, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Backman","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences, Uppsala University, Uppsala University Hospital, Rudbeck Laboratory , ,","place":["Uppsala, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Hellman","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences, Uppsala University, Uppsala University Hospital, Rudbeck Laboratory , ,","place":["Uppsala, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olov","family":"Norl\u00e9n","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences, Uppsala University, Uppsala University Hospital, Rudbeck Laboratory , ,","place":["Uppsala, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"St\u00e5lberg","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences, Uppsala University, Uppsala University Hospital, Rudbeck Laboratory , ,","place":["Uppsala, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,9,12]]},"reference":[{"key":"2026070711031268000_bib1","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13423","article-title":"European Neuroendocrine Tumor Society (ENETS) 2024 guidance paper for the management of well-differentiated small intestine neuroendocrine tumours","volume":"36","author":"Lamarca","year":"2024","journal-title":"J Neuroendocrinol"},{"key":"2026070711031268000_bib2","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00268-011-1296-z","article-title":"Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center","volume":"36","author":"Norlen","year":"2012","journal-title":"World J Surg"},{"key":"2026070711031268000_bib3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/jamaoncol.2017.3326","article-title":"Association of a prophylactic surgical approach to stage IV small intestinal neuroendocrine tumors with survival","volume":"4","author":"Daskalakis","year":"2018","journal-title":"JAMA Oncol"},{"key":"2026070711031268000_bib4","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1172\/JCI67963","article-title":"The genomic landscape of small intestine neuroendocrine tumors","volume":"123","author":"Banck","year":"2013","journal-title":"J Clin Invest"},{"key":"2026070711031268000_bib5","doi-asserted-by":"crossref","first-page":"987","DOI":"10.4161\/epi.28936","article-title":"Global hypomethylation and promoter methylation in small intestinal neuroendocrine tumors: an in vivo and in vitro study","volume":"9","author":"Fotouhi","year":"2014","journal-title":"Epigenetics"},{"key":"2026070711031268000_bib6","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1158\/1078-0432.CCR-15-0373","article-title":"Prognostic impact of novel molecular subtypes of small intestinal neuroendocrine tumor","volume":"22","author":"Karpathakis","year":"2016","journal-title":"Clin Cancer Res"},{"key":"2026070711031268000_bib7","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/ng.2821","article-title":"Somatic mutation of CDKN1B in small intestine neuroendocrine tumors","volume":"45","author":"Francis","year":"2013","journal-title":"Nat Genet"},{"key":"2026070711031268000_bib8","doi-asserted-by":"crossref","first-page":"S1428","DOI":"10.1245\/s10434-014-4351-9","article-title":"Somatic mutations and genetic heterogeneity at the CDKN1B locus in small intestinal neuroendocrine tumors","volume":"22","author":"Crona","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"2026070711031268000_bib9","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/ijc.1276","article-title":"Chromosome 18 deletions are common events in classical midgut carcinoid tumors","volume":"92","author":"Lollgen","year":"2001","journal-title":"Int J Cancer"},{"key":"2026070711031268000_bib10","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0002-9440(10)64136-3","article-title":"Comparative genomic hybridization identifies loss of 18q22-qter as an early and specific event in tumorigenesis of midgut carcinoids","volume":"158","author":"Kytola","year":"2001","journal-title":"Am J Pathol"},{"key":"2026070711031268000_bib11","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2217\/epi.15.39","article-title":"Methyl-CpG-binding domain proteins: readers of the epigenome","volume":"7","author":"Du","year":"2015","journal-title":"Epigenomics"},{"key":"2026070711031268000_bib12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fgene.2016.00093","article-title":"Emerging molecular and biological functions of MBD2, a reader of DNA methylation","volume":"7","author":"Wood","year":"2016","journal-title":"Front Genet"},{"key":"2026070711031268000_bib13","doi-asserted-by":"crossref","first-page":"9202","DOI":"10.1158\/0008-5472.CAN-06-1954","article-title":"Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo","volume":"66","author":"Shukeir","year":"2006","journal-title":"Cancer Res"},{"key":"2026070711031268000_bib14","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1158\/1541-7786.MCR-11-0252","article-title":"Methyl-binding domain protein 2-dependent proliferation and survival of breast cancer cells","volume":"9","author":"Mian","year":"2011","journal-title":"Mol Cancer Res"},{"key":"2026070711031268000_bib15","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ajpath.2019.01.010","article-title":"Methyl-CpG binding domain protein 2 inhibits the malignant characteristic of lung adenocarcinoma through the epigenetic modulation of 10 to 11 translocation 1 and miR-200s","volume":"189","author":"Pei","year":"2019","journal-title":"Am J Pathol"},{"key":"2026070711031268000_bib16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/carcin\/bgn240","article-title":"Specific association between the methyl-CpG-binding domain protein 2 and the hypermethylated region of the human telomerase reverse transcriptase promoter in cancer cells","volume":"30","author":"Chatagnon","year":"2009","journal-title":"Carcinogenesis"},{"key":"2026070711031268000_bib17","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0002-9440(10)64017-5","article-title":"A transplantable human carcinoid as model for somatostatin receptor-mediated and amine transporter-mediated radionuclide uptake","volume":"158","author":"Kolby","year":"2001","journal-title":"Am J Pathol"},{"key":"2026070711031268000_bib18","doi-asserted-by":"crossref","first-page":"X1","DOI":"10.1530\/ERC-17-0445e","article-title":"The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines","volume":"25","author":"Hofving","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"2026070711031268000_bib19","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1158\/1078-0432.CCR-06-2723","article-title":"The development and characterization of a human midgut carcinoid cell line","volume":"13","author":"Van Buren","year":"2007","journal-title":"Clin Cancer Res"},{"key":"2026070711031268000_bib20","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/carcin\/bgp073","article-title":"Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21","volume":"30","author":"Derks","year":"2009","journal-title":"Carcinogenesis"},{"key":"2026070711031268000_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/database\/baae030","article-title":"cancercelllines.org-a novel resource for genomic variants in cancer cell lines","volume":"2024","author":"Paloots","year":"2024","journal-title":"Database"},{"key":"2026070711031268000_bib22","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1530\/EC-19-0279","article-title":"PTPRM, a candidate tumor suppressor gene in small intestinal neuroendocrine tumors","volume":"8","author":"Barazeghi","year":"2019","journal-title":"Endocr Connect"},{"key":"2026070711031268000_bib23","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000446917","article-title":"Loss of chromosome 18 in neuroendocrine tumors of the small intestine: the Enigma remains","volume":"104","author":"Nieser","year":"2017","journal-title":"Neuroendocrinology"},{"key":"2026070711031268000_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12885-021-07786-9","article-title":"SMAD4 haploinsufficiency in small intestinal neuroendocrine tumors","volume":"21","author":"Hofving","year":"2021","journal-title":"BMC Cancer"},{"key":"2026070711031268000_bib25","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.1158\/0008-5472.CAN-11-1157","article-title":"Overexpression of MBD2 in glioblastoma maintains epigenetic silencing and inhibits the antiangiogenic function of the tumor suppressor gene Bai1","volume":"71","author":"Zhu","year":"2011","journal-title":"Cancer Res"},{"key":"2026070711031268000_bib26","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1007\/s13277-013-1455-y","article-title":"Reduced mRNA expression levels of MBD2 and MBD3 in gastric carcinogenesis","volume":"35","author":"Pontes","year":"2014","journal-title":"Tumour Biol"},{"key":"2026070711031268000_bib27","article-title":"NET Models Meeting 2024 white paper: the current state of neuroendocrine tumour research models and our future aspirations","volume":"4","author":"Ear","year":"2024","journal-title":"Endocr Oncol"},{"key":"2026070711031268000_bib28","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","article-title":"EMT transition states during tumor progression and metastasis","volume":"29","author":"Pastushenko","year":"2019","journal-title":"Trends Cell Biol"},{"key":"2026070711031268000_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","article-title":"New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer","volume":"20","author":"Dongre","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2026070711031268000_bib30","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3390\/cells8101118","article-title":"The E-cadherin and N-cadherin switch in epithelial-to-mesenchymal transition: signaling, therapeutic implications, and challenges","volume":"8","author":"Loh","year":"2019","journal-title":"Cells"}],"container-title":["Endocrine Connections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ec.bioscientifica.com\/view\/journals\/ec\/14\/9\/EC-25-0169.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/14\/9\/EC-25-0169.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-25-0169\/10145\/ec-25-0169.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-25-0169\/10145\/ec-25-0169.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:42:22Z","timestamp":1783438942000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article\/14\/9\/e250169\/1486\/Loss-of-MBD2-is-associated-with-tumor-growth-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9,1]]}},"URL":"https:\/\/doi.org\/10.1530\/ec-25-0169","relation":{},"ISSN":["2049-3614"],"issn-type":[{"value":"2049-3614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"article-number":"e250169"}}